SCHEMBL30722960

SCHEMBL30722960

C[C@@H](C[C@H]1CC[C@H](NC(=O)OC(C)(C)C)CC1)NC(=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.52
SYK P43405 1/20 0.51
TSHR P16473 1/20 0.50
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
DRD2 P14416 2/20 0.47
KDM1A O60341 1/20 0.47
MAOB P27338 1/20 0.47
CTSK P43235 6/20 0.45
EPHX1 P07099 1/20 0.45
DPP4 P27487 3/20 0.45
DPP7 Q9UHL4 3/20 0.45
KCNH2 Q12809 1/20 0.45
CTSL P07711 2/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30722961 1.00 ALDH1A1 (0.52) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL23818877 0.86 ALDH1A1 (0.50) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL30089900 0.86 ALDH1A1 (0.50) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL3944460 0.85 ALDH1A1 (0.69) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL6153463 0.85 ALDH1A1 (0.69) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL3944464 0.85 ALDH1A1 (0.69) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL29362806 0.85 ALDH1A1 (0.54) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL3946631 0.83 ALDH1A1 (0.56) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL3946595 0.83 ALDH1A1 (0.56) ALDH1A1GAASYKTSHRKMT2A
SCHEMBL7209388 0.83 ALDH1A1 (0.56) ALDH1A1GAASYKTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4541791-A1 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2025-04-23 EP disclosed
CN-119365445-A Dihydrooxadiazinon compounds and pharmaceutical uses thereof 日本烟草产业株式会社 2025-01-24 CN disclosed
US-20240101572-A1 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2024-03-28 US disclosed
WO-2023243686-A1 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF 日本たばこ産業株式会社 2023-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101572-A1 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF PLD2, PLD1, PLD4 ALDH1A1 1420/4885GAA 914/4885SYK 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.